<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="75367">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01675544</url>
  </required_header>
  <id_info>
    <org_study_id>12-16350</org_study_id>
    <nct_id>NCT01675544</nct_id>
  </id_info>
  <brief_title>PRospective Evaluation of Electrocardiographic Voltage Changes and Six Minute Walk Test for Predicting Readmissions in Heart Failure (PREEMT-HF Study)</brief_title>
  <acronym>PREEMT-HF</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Creighton University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Creighton University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose of the study: To identify whether Electrocardiographic QRS voltage changes (between
      admission and pre-discharge) and pre discharge 6- minute walk test in patients admitted with
      acute heart failure can identify patients at risk for recurrent admissions for heart
      failure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary Objective Determine the ability of EKG voltage changes and pre discharge 6-minute
      walk test (6-MWT) to predict repeat heart failure hospitalization (HFH) in patients admitted
      with acute decompensated heart failure (ADHF).

      Secondary Objectives

        1. Determine the ability of EKG voltage changes and pre discharge 6-MWT) to predict a
           composite of 1 year mortality and HFH in patients admitted with ADHF.

        2. Determine the ability of proportionate pulse pressure, orthostatic blood pressure
           changes and pre discharge inferior vena cava (IVC) diameter by portable ultrasound to
           predict HFH and mortality
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Emergency room visit or hospitalization for acute decompensated heart failure (ADHF)</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>All cause mortality at 1 year</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Heart Failure Admission</arm_group_label>
    <description>Patients admitted for acute decompensated heart failure</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Electrocardiogram</intervention_name>
    <description>EKG voltage changes between admission and discharge</description>
    <arm_group_label>Heart Failure Admission</arm_group_label>
    <other_name>EKG</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Six minute walk test</intervention_name>
    <arm_group_label>Heart Failure Admission</arm_group_label>
    <other_name>6-MWT</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted with acute decompensated heart failure
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients &gt; 18 years of age, admitted with a diagnosis of ADHF and fulfilling the
             following criteria:

               1. Evidence of systemic congestion (manifested by any 2 of the following criteria:
                  jugular venous distension, edema, pulmonary rales, Left ventricular S3, or
                  radiographic evidence of pulmonary venous congestion)

               2. Elevated Brain natriuretic peptide

               3. Need for at least 1 dose of intravenous loop diuretic

        Exclusion Criteria:

          -  Cardiogenic shock, Acute coronary syndromes (patients with mild elevation in troponin
             related to heart failure will not be excluded), patients who are admitted for another
             principal problem and develop ADHF in the hospital, pregnant females, end stage renal
             disease on hemodialysis, expected survival &lt; 6 months.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Venkata M Alla, MBBS</last_name>
    <phone>402-280-4566</phone>
    <email>venkataalla@creighton.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Creighton University Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Venkata M Alla, MBBS</last_name>
      <phone>402-280-4566</phone>
      <email>venkataalla@creighton.edu</email>
    </contact>
    <investigator>
      <last_name>Venkata M Alla, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 27, 2014</lastchanged_date>
  <firstreceived_date>August 28, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart failure</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
